The 105321 rule spaces disruptive actions: 10 h before bed avoid caffeine
The case for stacking BPC-157 and TB-500 comes down to this: they work on different phases through different mechanisms, so combining them addresses more of the healing cascade than either alone
In recent years, independent research groups have begun to replicate some of these findings, adding credibility to the Zagreb team's extensive work
Instead, other interventions are typically warranted such as reformulation to remove reactants, inclusion of oxygen absorbers, or modified atmosphere packaging
In preclinical studies, BPC-157 is typically dosed at 200500 mcg/kg, TB-500 at 210 mg/kg, and GHK-Cu at 13 mg/kg, administered via subcutaneous injection, intravenous infusion, or direct tissue injection depending on study design